Glassman Wealth Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Glassman Wealth Services's DGX Position: Q1 2024 in Review
Glassman Wealth Services sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 194 shares — an estimated $26.7K sold.
Glassman Wealth Services first reported a position in DGX in Q3 2016 and held it in 30 quarters. The position peaked at $53K in Q4 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.
- Glassman Wealth Services reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 194 Quest Diagnostics shares in Q1 2024, an estimated $26.7K.
- Glassman Wealth Services first reported a position in Quest Diagnostics in Q3 2016 and held it in 30 quarters.
- Glassman Wealth Services's Quest Diagnostics position peaked at $53K in Q4 2021.
- 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.